Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wyeth has reported that it will appeal the verdicts in the case of Donna Scroggin versus Wyeth, in the US District Court of Arkansas, beginning with post-trial motions.
Subscribe to our email newsletter
On February 25, 2008, the jury awarded the plaintiff $2.75 million in compensatory damages against Wyeth and co-defendant Upjohn. After a second phase of the trial, the jury subsequently awarded $19.36 million in punitive damages against Wyeth and $7.7 million against Upjohn. The plaintiff alleged that she developed breast cancer from the use of Premarin and Prempro, products marketed by Wyeth. Premarin (conjugated estrogens tablets) and Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) are approved by the FDA as safe and effective when used as indicated.
Lyn Pruitt, an attorney with Mitchell, Williams, Selig, Gates & Woodyard, a firm representing Wyeth in the case, said: “There is no basis in fact or law for this award or for the earlier compensatory damage award. We will pursue several post-trial motions and will ultimately appeal the entire case if necessary.”